content top

Use of Subretinal t-pa in Macular Hemorrhages in Wet AMD

ABSTRACT Wet AMD is one of the most frequent ophthalmic disorders. Thanks to anti-VEGF medications, which have been successfully used in this condition since 2006, there is a good chance of maintaining useful visual acuity in majority of patient with CNV. Efficacy of anti-VEGF drugs reduced the frequency of surgical methods used to treat wet AMD. There are however cases which, if not treated in more aggressive way, would not have chances...

Read More

First Year Outcomes of Cataract Surgery Combined with Intravitreal Ranibizumab Injection in Neovascular Age-related Macular Degeneration

ABSTRACT Purpose: To evaluate the visual and anatomic outcomes of patients who underwent phacoemulsification combined with intravitreal ranibizumab (IVR) injection in neovascular age related macular degeneration (nAMD). Setting: Department of opthalmology, Mugla Sitki Kocman University Faculty of Medicine Methods: The first year visual and anatomic outcomes of 50 eyes of 50 nAMD patients were determined. Group 1 consisted of 19 eyes of 19...

Read More

The ILM Peeling Effect in Wet-AMD

ABSTRACT Aim: To evaluate the role of small gauge PPV and ILM peeling in patients diagnosed with different type of CNV secondary to ARMD. Patients & Method: Nineteen eyes of 16 patients, with a mean age of 69.5±8.9 years, were retrospectively evaluated during a minimum of 24 months. Results: The mean baseline BCVA was 0.91 ± 0.12 logMAR, improved to 0.82 ± 0.19 logMAR after 12 months (p<0.01) and remained stable over 24...

Read More

Corticosteroid Intravitreal Treatment in AMD Patient with a Recent Stroke

ABSTRACT Introduction: Anti-angiogenic treatment with anti-vascular endothelial growth factor (anti-VEGF) for patients with exudative neovascular age-related macular degeneration (AMD) is the most effective in slowing the progression of visual loss and is first choice therapy. The safety data in patients with cerebrovascular accidents (CVA) in the last 6 months is limited since this condition has been considered as an exclusion criterion in...

Read More

Early Clinical Results with Eyemax Mono Extended Macular Vision Intraocular Lens in Patients with Intermediate to Advanced AMD

ABSTRACT Purpose: To determine safety and visual outcomes in eyes with advanced age-related macular degeneration (AMD) implanted with a novel intraocular lens (IOL) that delivers an optimized retinal image to all macular areas within 10 degrees of retinal eccentricity. Methods: This was a consecutive case series of 11 eyes of 9 patients with advanced stage AMD. Eyemax monoTM (London Eye Hospital Pharma), a single-piece, injectable,...

Read More

Three-Dimensional Analysis of the Morphological Changes and Visual Outcomes in Neovascular Age-Related Macular Degeneration

ABSTRACT Purpose: To investigate the association of 3-D quantified lesions with best-corrected visual acuity (BCVA) in AMD. Methods: We retrospectively analyzed 65 eyes of 61 typical nAMD patients. Lesions at baseline and month 12 were manually delineated in OCT. Volumes of intraretinal fluid (IRF), subretinal fluid (SRF), subretinal hyperreflective material (SHRM), and pigment epithelial detachment (PED) were measured. Results: At...

Read More
content top